Your session is about to expire
← Back to Search
Other
Tailored Advice Tool for Weight Loss
N/A
Waitlist Available
Led By Brooke Nezami, PhD, MA
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a new tool can help people lose weight, by giving tailored advice based on reinforcement learning.
Who is the study for?
This trial is for adults aged 18-55 with a BMI of 25-40 who are not meeting US physical activity guidelines, can speak and write English, have no major health issues that limit exercise, and own a smartphone. Excluded are those on weight loss meds, pregnant or planning pregnancy soon, with certain medical conditions like diabetes requiring insulin treatment or recent cancer treatment.
What is being tested?
The ADAPT study is testing the AdaptRL tool over 12 weeks to see if it helps people lose weight by suggesting personalized behavior change techniques. It builds on an existing approach that adjusts support based on how individuals respond to different contexts in real-time.
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue. There might also be psychological impacts from changing diet and activity habits.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Feasibility (success of using the AdaptRL model)
Self-monitoring adherence
Study engagement
Secondary study objectives
Achievement of active minutes goal
Achievement of active minutes goal percent of person-days
Achievement of calorie goal (at or under goal)
+10 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: ADAPT interventionExperimental Treatment1 Intervention
Participants will receive a smart scale and a physical activity tracker and will have three daily goals: weigh daily, a daily personalized active minutes goal, and a daily calorie goal. For 12 weeks, participants will receive 0-3 text messages per day about their behaviors and progress towards their goals which they will be able to rate (like/dislike), along with weekly personalized feedback, progress graphs, and lessons and resources available on the website.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADAPT
2015
N/A
~570
Find a Location
Who is running the clinical trial?
RTI InternationalOTHER
196 Previous Clinical Trials
844,526 Total Patients Enrolled
3 Trials studying Obesity
1,799 Patients Enrolled for Obesity
UNC Lineberger Comprehensive Cancer CenterLead Sponsor
362 Previous Clinical Trials
91,966 Total Patients Enrolled
2 Trials studying Obesity
118 Patients Enrolled for Obesity
National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,012,012 Total Patients Enrolled
50 Trials studying Obesity
32,248 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have heart or bone issues, or take medicine for blood pressure or heart conditions.I have Type 1 diabetes or am being treated for Type 2 diabetes.I have received cancer treatment in the last 5 years.I have had weight loss surgery.I am currently on medication to lose weight.I have lost 10 or more pounds and kept it off for the last 6 months.I have tuberculosis.I am not willing to attend two study visits.I am not willing to wear a Fitbit daily.I am between 18 and 55 years old.I do not have health or psychological conditions that prevent me from following a diet and exercise program.I have been diagnosed with or treated for an eating disorder.I can follow an exercise program on my own and don't have diabetes (treated with insulin), heart issues, or current cancer treatment.
Research Study Groups:
This trial has the following groups:- Group 1: ADAPT intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger